Clinical Trials

55 enrolled

Recurrence, Hematologic Neoplasms

NCT07527221 2026-04-14

Safety and Tolerability of ZE74-0282 in Healthy Volunteers

40 enrolled

Polycythemia, Thrombocythemia, Essential, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Primary Myelofibrosis

NCT07012044 2026-04-13

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

47 enrolled

Leukemia, Myeloid, Acute

NCT07513129 2026-04-13

A Phase 1 Study Of Venetoclax, Dexamethasone, Bortezomib, And Daratumumab (VDBD) For Adolescent And Young Adult Patients With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And Lymphomas

18 enrolled

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07518329 2026-04-08

Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.

46 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

NCT07518654 2026-04-08

ThINKK-01

CNSLymphoidOther hematologic neoplasm

Paroxysmal nonkinesigenic dyskinesia, Leukemia, Neoplasm Metastasis, Neuroblastoma, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07254793 2026-04-07

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

LymphoidMyeloidOther hematologic neoplasm

94 enrolled

Lymphoma, Non-Hodgkin, Motor Activity, Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07511062 2026-04-06

Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML

32 enrolled

Leukemia, Myeloid, Acute

NCT07374029 2026-04-03

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

30 enrolled

Leukemia, Myeloid, Acute

NCT07498465 2026-03-27

A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia

29 enrolled

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07485504 2026-03-20

Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies

Recurrence, Hematologic Neoplasms

NCT07464951 2026-03-11

CART123

30 enrolled

Leukemia, Leukemia, Myeloid, Acute

NCT07220993 2026-03-04

Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells

27 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07297160 2026-03-04

CALySSEY

GenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

88 enrolled

Kidney Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT07439211 2026-03-03

GAVEL

48 enrolled

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT07441980 2026-03-02

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

18 enrolled

Leukemia, Myeloid, Acute

NCT07432100 2026-02-25

Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT07428486 2026-02-23

A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07424833 2026-02-20

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

180 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07392814 2026-02-17

TOCIVENA

Leukemia

NCT07411586 2026-02-17

Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT07355335 2026-01-22

Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML

Leukemia, Myeloid, Acute

NCT07347418 2026-01-16

CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML or HR-MDS

23 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT07316907 2026-01-05

A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies

Lymphoma, Recurrence, Hematologic Neoplasms

NCT07306832 2025-12-29

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

18 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT07303660 2025-12-26

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

66 enrolled

Leukemia, Myeloid, Acute

NCT07166549 2025-12-24

BaseCAR-01

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07283640 2025-12-22

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07294300 2025-12-19

A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies

124 enrolled

Hematologic Neoplasms

NCT06345027 2025-12-16

CASEY

Leukemia, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT07255898 2025-12-01

A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies

Other hematologic neoplasmPlasma cell

33 enrolled

Multiple Myeloma, Hematologic Neoplasms

NCT07233018 2025-11-18

A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT07225439 2025-11-06

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

60 enrolled

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

NCT07120607 2025-08-13

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

9 enrolled

Leukemia

NCT06996119 2025-05-30

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06894693 2025-03-25

A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies

13 enrolled

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05662904 2025-03-14

GALAXY33

Leukemia, Myeloid, Acute

NCT06696846 2024-11-20

CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia

25 enrolled

Leukemia, Myeloid, Acute, Lymphoma, T-Cell

NCT06672263 2024-11-04

A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia

120 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06655519 2024-10-23

An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

NCT06641024 2024-10-15

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALL

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06641648 2024-10-15

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

Recurrence, Leukemia, Myeloid, Acute

NCT06530810 2024-07-31

Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)

100 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT06528249 2024-07-30

Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies

39 enrolled

Neoplasms, Hematologic Neoplasms

NCT06463327 2024-06-17

ACHIEVE2

69 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06441084 2024-06-04

A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

Leukemia, Myeloid, Acute

NCT06347458 2024-04-04

BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children

Leukemia, Leukemia, Myeloid, Acute

NCT06252584 2024-02-09

AML-VAC-XS15